US 12,492,184 B2
Heteroaryl compounds, preparation methods and uses thereof
Xing Dai, Short Hills, NJ (US)
Assigned to InventisBio Co., Ltd., Shanghai (CN); and InventisBio LLC, Short Hills, NJ (US)
Appl. No. 18/268,681
Filed by InventisBio Co., Ltd., Shanghai (CN); and InventisBio LLC, Florham Park, NJ (US)
PCT Filed Dec. 22, 2021, PCT No. PCT/CN2021/140271
§ 371(c)(1), (2) Date Jun. 21, 2023,
PCT Pub. No. WO2022/135430, PCT Pub. Date Jun. 30, 2022.
Claims priority of application No. PCT/CN2020/138305 (WO), filed on Dec. 22, 2020; and application No. PCT/CN2021/086083 (WO), filed on Apr. 9, 2021.
Prior Publication US 2024/0140929 A1, May 2, 2024
Int. Cl. C07D 401/12 (2006.01); C07D 213/75 (2006.01); C07D 237/24 (2006.01); C07D 253/075 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 513/04 (2006.01)
CPC C07D 401/12 (2013.01) [C07D 213/75 (2013.01); C07D 237/24 (2013.01); C07D 253/075 (2013.01); C07D 401/14 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 513/04 (2013.01)] 2 Claims
 
1. A compound, or a pharmaceutically acceptable salt thereof, wherein the compound is

OG Complex Work Unit Chemistry